More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – Endogenex, Vaxess, and more

    This week’s MedTech funding rounds underscore accelerating innovation across metabolic health, precision oncology, and advanced drug-delivery platforms. Investors are backing companies driving clinical trials, scaling manufacturing, and preparing pivotal regulatory submissions Endogenex raises $50M to...

    GS MedTech Funding Tracker – Endogenex, Vaxess, and more

    This week’s MedTech funding rounds underscore accelerating innovation across metabolic health, precision oncology, and advanced drug-delivery platforms. Investors are backing companies driving clinical trials,...

    Virchow raises $4M to advance biopsy stewardship and precision oncology access

    Virchow Medical, manufacturer of the Crow’s Nest® Biopsy Catchment System and operator of the Virchow VaultTM Liquid Specimen Biorepository, announced it has completed a...

    Vaxess rebrands to Terrestrial Bio, raises $50M for GLP-1 patch

    Vaxess Technologies announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing. Boston-based Terrestrial Bio rebranded to reflect its strategic...

    Endogenex raises $50M to advance type 2 diabetes treatment

    Endogenex has raised $50m in funding, setting the company up with sufficient funds to complete a pivotal trial of its type 2 diabetes (T2D)...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – Endogenex, Vaxess, and more

    This week’s MedTech funding rounds underscore accelerating innovation across metabolic health, precision oncology, and advanced drug-delivery platforms. Investors are backing companies driving clinical trials,...

    Virchow raises $4M to advance biopsy stewardship and precision oncology access

    Virchow Medical, manufacturer of the Crow’s Nest® Biopsy Catchment System and operator of the Virchow VaultTM Liquid Specimen Biorepository, announced it has completed a...

    Vaxess rebrands to Terrestrial Bio, raises $50M for GLP-1 patch

    Vaxess Technologies announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing. Boston-based Terrestrial Bio rebranded to reflect its strategic...

    Endogenex raises $50M to advance type 2 diabetes treatment

    Endogenex has raised $50m in funding, setting the company up with sufficient funds to complete a pivotal trial of its type 2 diabetes (T2D)...

    M&A

    Archives

    Latest articles